This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Benefits of Chromium Picolinate In Diabetes Management

Posted: Thursday, February 08, 2007

In a peer-reviewed analysis, it was shown that chromium picolinate has a positive effect in improving glycemic control and lipids in Type 2 diabetes.

In a published peer-reviewed analysis on chromium picolinate in the current edition of Diabetes Technology & Therapeutics. The analysis confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes. The review, which analyzed research on chromium picolinate, supports the consistent beneficial effects of chromium picolinate and refutes a previous review that analyzed efficacy after combining results from all types of supplemental chromium.

"The main messages are that all forms of chromium are not equivalent, and that higher doses of chromium picolinate are required for people with type 2 diabetes," said C. Leigh Broadhurst, PhD, Research Chemist, the lead author of the publication. "Previous chromium reviews examined all types of chromium at widely varying doses. But separating out chromium picolinate, which yields highly consistent results in research studies, compared to other chromium supplements shows that at doses between 200-1000 mcg it is a superior nutritional adjunct to diabetes treatments."

The review analyzed 15 clinical studies of people with diabetes. All studies showed chromium picolinate produced benefits in one or more standard measures of diabetes management, with no adverse events reported. The studies examined people with type 2, type 1, gestational and corticosteroid-induced diabetes. Although glycemic control varied by trial, all 15 trials showed improvements in one or more measurements of glycemic control, including fasting glucose, postprandial glucose, fasting insulin, postprandial insulin, glycated hemoglobin, or insulin sensitivity.

The authors concluded the greater bioavailability of chromium picolinate compared to other forms of chromium may explain its comparatively significant superior effects on glycemic and lipidemic control. Supplemental chromium is available in several forms, including chromium picolinate, chromium chloride, and chromium nicotinate. Research indicates that chromium picolinate, the most studied form of chromium, has enhanced absorption and efficacy.

The studies reviewed in this paper were identified from a number of sources, such as PubMed, Science Direct, and a past review of chromium effects on glycemic control. A total of 1,690 subjects, including 1,505 receiving chromium picolinate, participated in these trials. Twelve of the 15 studies were randomized, controlled trials and three were open-label trials. Chromium picolinate dosages ranged from 200-1000 mcg chromium per day, and the duration of the supplementation ranged from one week to 10 months.

Chromium picolinate, which is sold in combination with the B-vitamin biotin under the brand name of Diachrome(R) for people with diabetes, is an essential trace mineral that helps to regulate insulin function. The chromium picolinate in Diachrome has been recognized as safe by many of the world's leading government and academic research institutions, including the U.S. Food and Drug Administration, the Institute of Medicine and the UK's Food Standards Agency. In addition, biotin has been deemed safe by the U.S. Food and Drug Administration and is also Generally Recognized as Safe (GRAS) for use in foods and supplements.

Source: Diabetes In Control: Diabetes Technology and Therapeutics Volume 8, Number 6, Pages 677-687: “Clinical Studies on Chromium Picolinate Supplementation in Diabetes Mellitus - A Review” Authors: C.L. Broadhurst, P. Domenico